Mizuho Securities

mizuho-upgrades-sarepta-therapeutics-to-outperform-with-26-target

Mizuho Upgrades Sarepta Therapeutics to Outperform with $26 Target

Editorial 6 November, 2025

Mizuho Securities has upgraded its rating for Sarepta Therapeutics (NASDAQ: SRPT) from neutral to...

unitedhealth-shares-decline-following-doj-investigation-announcement

UnitedHealth Shares Decline Following DOJ Investigation Announcement

Editorial 24 July, 2025

Shares of UnitedHealth Group faced a significant decline following the announcement of a federal...